Comparing the DNA hypermethylome with gene mutations in human colorectal cancer.

  • Chan T
  • Schuebel K
  • van Den Bosch S
 et al. 
  • 1

    Readers

    Mendeley users who have this article in their library.
  • N/A

    Citations

    Citations of this article.

Abstract

We have developed a transcriptome-wide approach to identify genes affected by promoter CpG island DNA hypermethylation and transcriptional silencing in colorectal cancer. By screening cell lines and validating tumor-specific hypermethylation in a panel of primary human colorectal cancer samples, we estimate that nearly 5% or more of all known genes may be promoter methylated in an individual tumor. When directly compared to gene mutations, we find larger numbers of genes hypermethylated in individual tumors, and a higher frequency of hypermethylation within individual genes harboring either genetic or epigenetic changes. Thus, to enumerate the full spectrum of alterations in the human cancer genome, and to facilitate the most efficacious grouping of tumors to identify cancer biomarkers and tailor therapeutic approaches, both genetic and epigenetic screens should be undertaken.

Author-supplied keywords

  • Base Sequence
  • Colorectal Neoplasms
  • Colorectal Neoplasms: genetics
  • CpG Islands
  • DNA Methylation
  • DNA Primers
  • Genetic
  • Humans
  • Mutation
  • Promoter Regions
  • Reverse Transcriptase Polymerase Chain Reaction

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document

Authors

  • Timothy A Chan

  • Kornel E Schuebel

  • Sandra van Den Bosch

  • Wei Chen

  • Leslie Cope

  • Sabine C Glöckner

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free